Literature DB >> 19466545

Association of interleukin-18 gene polymorphisms with hepatitis B virus clearance.

Jae Youn Cheong1, Sung Won Cho, Bermseok Oh, Kuchan Kimm, Kee Myung Lee, Sung Jae Shin, Jung A Lee, Byung Lae Park, Hyun Sub Cheong, Hyoung Doo Shin, Bo Young Cho, Jin Hong Kim.   

Abstract

The outcome of hepatitis B virus (HBV) infection can be affected by host immune factors. Interleukin-18 (IL-18) was originally discovered as an interferon-gamma-inducing factor and plays a critical role in immune response. We assessed the association between the clearance of HBV infection and single-nucleotide polymorphisms (SNPs) in the IL-18 gene. Between March 2002 and December 2004, a total of 1,050 Korean subjects were enrolled in the study and divided into two groups: (1) the HBV spontaneous recovery group (n = 320) and (2) the chronic HBV carrier group (n = 730). We analyzed SNPs at four polymorphic sites in the IL-18 gene at positions -667G>T, -148G>C, +8925C>G, and +13925A>C. We observed that the subjects bearing the IL-18 -148C allele [odds ratio (OR), 0.25; confidence interval (CI), 0.09-0.68; P = 0.01], the +8925G allele (OR, 0.36; CI, 0.15-0.88; P = 0.02), and the +13925C allele (OR, 0.25; CI, 0.13-0.82; P = 0.01) were significantly associated with HBV clearance in a recessive model. This study indicates that the -148C, +8925G, and +13925C alleles of the IL-18 gene are likely associated with HBV clearance in a Korean population.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19466545     DOI: 10.1007/s10620-009-0819-z

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  27 in total

1.  An essential role for NF-kappa B in IL-18-induced IFN-gamma expression in KG-1 cells.

Authors:  H Kojima; Y Aizawa; Y Yanai; K Nagaoka; M Takeuchi; T Ohta; H Ikegami; M Ikeda; M Kurimoto
Journal:  J Immunol       Date:  1999-05-01       Impact factor: 5.422

2.  Chronic hepatitis B.

Authors:  Anna S F Lok; Brian J McMahon
Journal:  Hepatology       Date:  2007-02       Impact factor: 17.425

3.  Differential capacities of CD4+, CD8+, and CD4-CD8- T cell subsets to express IL-18 receptor and produce IFN-gamma in response to IL-18.

Authors:  M Tomura; S Maruo; J Mu; X Y Zhou; H J Ahn; T Hamaoka; H Okamura; K Nakanishi; S Clark; M Kurimoto; H Fujiwara
Journal:  J Immunol       Date:  1998-04-15       Impact factor: 5.422

4.  Urban-rural comparison of HBV and HCV infection prevalence among adult women in Shandong Province, China.

Authors:  S Shimbo; Z W Zhang; J B Qu; J J Wang; C L Zhang; L H Song; T Watanabe; K Higashikawa; M Ikeda
Journal:  Southeast Asian J Trop Med Public Health       Date:  1997-09       Impact factor: 0.267

5.  HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection.

Authors:  R Nayersina; P Fowler; S Guilhot; G Missale; A Cerny; H J Schlicht; A Vitiello; R Chesnut; J L Person; A G Redeker; F V Chisari
Journal:  J Immunol       Date:  1993-05-15       Impact factor: 5.422

6.  Lack of association between hepatitis B virus infection and polymorphism of mannose-binding lectin gene in Korean population.

Authors:  Jae Youn Cheong; Sung Won Cho; Sun Kyo Lim; Do Hyun Shin; Seung Kew Yoon; Jong Eun Lee; Ki Baik Hahm; Jin Hong Kim
Journal:  J Korean Med Sci       Date:  2005-02       Impact factor: 2.153

7.  Cytokine inhibition of the hepatitis B virus core promoter.

Authors:  R Romero; J E Lavine
Journal:  Hepatology       Date:  1996-01       Impact factor: 17.425

8.  Predominant T-helper 1 cytokine profile of hepatitis B virus nucleocapsid-specific T cells in acute self-limited hepatitis B.

Authors:  A Penna; G Del Prete; A Cavalli; A Bertoletti; M M D'Elios; R Sorrentino; M D'Amato; C Boni; M Pilli; F Fiaccadori; C Ferrari
Journal:  Hepatology       Date:  1997-04       Impact factor: 17.425

9.  Interleukin-18 inhibits hepatitis B virus replication in the livers of transgenic mice.

Authors:  Kiminori Kimura; Kazuhiro Kakimi; Stefan Wieland; Luca G Guidotti; Francis V Chisari
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

10.  Mechanisms of class I restricted immunopathology. A transgenic mouse model of fulminant hepatitis.

Authors:  K Ando; T Moriyama; L G Guidotti; S Wirth; R D Schreiber; H J Schlicht; S N Huang; F V Chisari
Journal:  J Exp Med       Date:  1993-11-01       Impact factor: 14.307

View more
  18 in total

1.  Elevated pre-treatment IL-18 level is associated with HBeAg seroconversion in HIV-HBV coinfection.

Authors:  Yijia Li; Jing Xie; Huanling Wang; Yang Han; Nidan Wang; Chloe L Thio; Taisheng Li
Journal:  Antivir Ther       Date:  2017-02-14

2.  High plasma interleukin-18 levels mark the acute phase of hepatitis C virus infection.

Authors:  Michael A Chattergoon; Jordana S Levine; Rachel Latanich; William O Osburn; David L Thomas; Andrea L Cox
Journal:  J Infect Dis       Date:  2011-10-07       Impact factor: 5.226

3.  Temporal dynamics of inflammatory cytokines/chemokines during sofosbuvir and ribavirin therapy for genotype 2 and 3 hepatitis C infection.

Authors:  Aaron F Carlin; Paula Aristizabal; Qinghua Song; Huan Wang; Matthew S Paulson; Luisa M Stamm; Robert T Schooley; David L Wyles
Journal:  Hepatology       Date:  2015-08-22       Impact factor: 17.425

4.  Efficacy of Hepatitis B Vaccination among Children in Special Region of Yogyakarta, Indonesia: Evaluation of Humoral and Cellular Immunity.

Authors:  Caessar Pronocitro; Nenny Sri Mulyani; Afif Avicenna Ghufron; Yugata Halimawan Hazazi; Bambang Ardianto; Didik Setyo Heriyanto
Journal:  Kobe J Med Sci       Date:  2018-01-17

Review 5.  Molecular mechanisms underlying occult hepatitis B virus infection.

Authors:  Jasmine Samal; Manish Kandpal; Perumal Vivekanandan
Journal:  Clin Microbiol Rev       Date:  2012-01       Impact factor: 26.132

6.  Association of GNLY genetic polymorphisms with chronic liver disease in a Korean population.

Authors:  Geun-Hee Park; Kyoung-Yeon Kim; Jae Youn Cheong; Sung Won Cho; KyuBum Kwack
Journal:  DNA Cell Biol       Date:  2012-07-12       Impact factor: 3.311

7.  Relationship between interleukin 18 polymorphisms and susceptibility to chronic hepatitis B virus infection.

Authors:  Na Li; Yu-Feng Gao; Tian-Chen Zhang; Ping Chen; Xu Li; Fei Su
Journal:  World J Hepatol       Date:  2012-03-27

Review 8.  Relationship between cytokine gene polymorphisms and chronic hepatitis B virus infection.

Authors:  Semra Tunçbilek
Journal:  World J Gastroenterol       Date:  2014-05-28       Impact factor: 5.742

9.  Relationship between interleukin-6 polymorphism and susceptibility to chronic hepatitis B virus infection.

Authors:  Xiao-Miao Zhao; Yu-Feng Gao; Qin Zhou; Fa-Ming Pan; Xu Li
Journal:  World J Gastroenterol       Date:  2013-10-28       Impact factor: 5.742

10.  Antibodies to hepatitis B virus surface antigen and interleukin 12 and interleukin 18 gene polymorphisms in hemodialysis patients.

Authors:  Alicja E Grzegorzewska; Piotr M Wobszal; Adrianna Mostowska; Paweł P Jagodziński
Journal:  BMC Nephrol       Date:  2012-08-03       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.